Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 1 hour ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 2 weeks agoIn a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...
Moderna turns to AI to change how its employees work
CIO Dive· 4 hours agoModerna hopes these tailored versions of the AI tool that made OpenAI famous will help boost its employees’ productivity as it attempts to bring 15 new vaccine and ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoHow the Moderna and Pfizer/BioNTech vaccines work is by targeting the spike protein in Covid-19...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 1 day agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 10 hours agoCerity Partners LLC increased its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 106.6% during the 4th quarter, according to the company in its most recent ...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
CNBC· 2 weeks agoThe biotech company said it has not received any vaccine orders for Africa since 2022 and has taken...
Moderna (NASDAQ:MRNA) Receives Hold Rating from Needham & Company LLC
ETF DAILY NEWS· 2 weeks agoSeveral other research analysts also recently weighed in on the company. William Blair reiterated a market perform rating on shares of Moderna in a report on Monday, April ...